More Choices to Treat Lung Cancer Advances in precision medicine and immunotherapy have led to better treatments for many patients with advanced lung cancer. But having a wider selection of therapies to choose from can make treatments more complex. by Kendall K. Morgan Forward Look What’s Next A therapeutic vaccine targeting advanced cervical cancer. by Anna Azvolinsky Worth the Wait Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients. by Sharon Tregaskis Facts and Stats Fall 2020 vol 10 | issue 3The advent of checkpoint inhibitors has broadened the range of cancer patients able to take advantage of immunotherapy. Targeted Therapy for Early-Stage Lung Cancer? A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion. by Ashley P. Taylor Support Grows for Making Transfusions a Part of Hospice Blood cancer patients have low rates of enrollment in hospice. One barrier to enrollment is that many hospices do not provide blood transfusions. by Jon Kelvey In It for the Long Haul Doctors and researchers met online to discuss how the coronavirus pandemic changed cancer care in its early months, as well as how they can improve care and advocate for patients going forward. by Kate Yandell From the Editor-In-Chief Measuring a Cancer Drug’s Effectiveness Surrogate endpoints can speed up drug approvals, but are they valid measures of effectiveness? by William G. Nelson, MD, PhD Forward Look Cancer Treatments and Antioxidant Supplements Can Be a Bad Mix Christine Ambrosone on what her research shows. by Sue Rochman Forward Look Here Come the Biosimilars As patents expire on biologic drugs, cancer patients get new options. by Stephen Ornes next Cancer Talk Planning to Survive Survivorship care plans can prepare cancer patients to get the best medical care and maintain their quality of life following treatment. by Carly Flumer Targeted Therapy for Early-Stage Lung Cancer? A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion. by Ashley P. Taylor Cervical Cancer Screening Guideline Updated A new version of the American Cancer Society’s cervical cancer screening guideline says screening can start at a later age and highlights human papillomavirus testing as the preferred method. by Anna Azvolinsky Support Grows for Making Transfusions a Part of Hospice Blood cancer patients have low rates of enrollment in hospice. One barrier to enrollment is that many hospices do not provide blood transfusions. by Jon Kelvey More Posts